Skip to main content
placeholder image

Trial in progress: A phase 1-2 multicenter, open-label, dose-escalation and dose-expansion study to evaluate the safety, pharmacokinetics, pharmacodynamics, and antitumor activity of ABN401 in patients with advanced solid tumors.

Journal Article


Abstract


UOW Authors


  •   De Souza, Paul (external author)

Publication Date


  • 2021

Citation


  • Lee, D. H., Roohullah, A., Cho, B. C., Lemech, C. R., de Souza, P. L., Millward, M., . . . Han, J. -Y. (2021). Trial in progress: A phase 1-2 multicenter, open-label, dose-escalation and dose-expansion study to evaluate the safety, pharmacokinetics, pharmacodynamics, and antitumor activity of ABN401 in patients with advanced solid tumors.. Journal of Clinical Oncology, 39(15_suppl), tps3157. doi:10.1200/jco.2021.39.15_suppl.tps3157

Web Of Science Accession Number


Start Page


  • tps3157

End Page


  • tps3157

Volume


  • 39

Issue


  • 15_suppl

Place Of Publication


Abstract


UOW Authors


  •   De Souza, Paul (external author)

Publication Date


  • 2021

Citation


  • Lee, D. H., Roohullah, A., Cho, B. C., Lemech, C. R., de Souza, P. L., Millward, M., . . . Han, J. -Y. (2021). Trial in progress: A phase 1-2 multicenter, open-label, dose-escalation and dose-expansion study to evaluate the safety, pharmacokinetics, pharmacodynamics, and antitumor activity of ABN401 in patients with advanced solid tumors.. Journal of Clinical Oncology, 39(15_suppl), tps3157. doi:10.1200/jco.2021.39.15_suppl.tps3157

Web Of Science Accession Number


Start Page


  • tps3157

End Page


  • tps3157

Volume


  • 39

Issue


  • 15_suppl

Place Of Publication